Xinxiang Tuoxin Pharmaceutical Co.Ltd. Capital Reinvestment Ratio
Xinxiang Tuoxin Pharmaceutical Co.Ltd. capital reinvestment ratio. Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Capital Reinvestment Ratio of 0.82x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥102.67 Million) in capital expenditures (CN¥83.91 Million). See Xinxiang Tuoxin Pharmaceutical Co.Ltd. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2024)
Capital reinvestment ratio of Xinxiang Tuoxin Pharmaceutical Co.Ltd. from 2019 to 2024. This chart tracks Xinxiang Tuoxin Pharmaceutical Co.Ltd.'s Capital Reinvestment Ratio across 6 annual periods. See financial agility of Xinxiang Tuoxin Pharmaceutical Co.Ltd. to measure the company's free cash flow as a share of total liabilities.
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Capital Reinvestment Ratio by Year (2019–2024)
Xinxiang Tuoxin Pharmaceutical Co.Ltd. capital reinvestment ratio by year from 2019 to 2024. For the full cash flow conversion analysis, see cash flow conversion of Xinxiang Tuoxin Pharmaceutical Co.Ltd..
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.82x | CN¥102.67 Million | CN¥83.91 Million | ▼ -88.1% |
| 2023 | 6.87x | CN¥26.95 Million | CN¥185.22 Million | ▲ +1145.5% |
| 2022 | 0.55x | CN¥268.85 Million | CN¥148.33 Million | ▼ -71.5% |
| 2021 | 1.94x | CN¥58.19 Million | CN¥112.73 Million | ▲ +213.6% |
| 2020 | 0.62x | CN¥120.00 Million | CN¥74.12 Million | ▼ -30.0% |
| 2019 | 0.88x | CN¥86.38 Million | CN¥76.20 Million | — |